T1	Participants 449 457	subjects
T2	Participants 1091 1097	groups
T3	Participants 788 818	allopurinol and placebo groups
T4	Participants 1068 1082	placebo group.
T5	Participants 1404 1417	placebo group
T6	Participants 1501 1512	both groups
